News & Views | Published:


Next-generation malarial vaccines

Nature Materialsvolume 18pages9496 (2019) | Download Citation

A vaccine platform developed from a synthetic polymeric glyco-adjuvant and reversibly conjugated to an antigen was shown to target dendritic cells leading to cellular and humoral immune response against malaria.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Seder, R. et al. Vaccine 33, B40–B43 (2015).

  2. 2.

    Wilson, D. S. et al. Nat. Mater. (2018).

  3. 3.

    Steinman, R. M. & Banchereau, J. Nature 449, 419–426 (2007).

  4. 4.

    Lambrecht, B. N., Kool, M., Willart, M. A. M. & Hammad, H. Curr. Opin. Immunol. 21, 23–29 (2011).

  5. 5.

    Idoyaga, J. et al. Proc. Natl Acad. Sci. USA 108, 2384–2389 (2011).

  6. 6.

    Burgdorf, S., Kautz, A., Böhnert, V., Knolle, P. A. & Kurts, C. Science 316, 612–616 (2007).

  7. 7.

    Kashem, S. W., Haniffa, M. & Kaplan, D. H. Annu. Rev. Immunol. 35, 469–499 (2017).

Download references

Author information


  1. Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

    • Yvette van Kooyk


  1. Search for Yvette van Kooyk in:

Corresponding author

Correspondence to Yvette van Kooyk.

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing